The main focus of the research group is in translational research in gynaecological cancers. In particular biomarker discovery and development (specifically immunological markers) in ovarian and endometrial cancers. The biomarkers are now in the process of being tested for diagnosis and surgical prognosis. The concept of predicting surgical outcome in ovarian cancer is a step in developing personalised medicine and providing patients with best care possible.
Recent advances in oncolgy have improved survival in patients with cancer but research into surgery may have additional benefits for the patient. Clinical research into optimal treatment of cervival preinvasive lesions has been a focus. We have shown that clear margins of resection has a significant effect on reducing risk of recurrence from preinvasive disease.
et al., 2019, The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome, Genetics in Medicine, ISSN:1098-3600
et al., 2019, Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes Scientific Impact Paper No. 58, Bjog-an International Journal of Obstetrics and Gynaecology, Vol:126, ISSN:1470-0328, Pages:E107-E113
et al., 2019, Uterine transplantation in transgender women, Bjog-an International Journal of Obstetrics and Gynaecology, Vol:126, ISSN:1470-0328, Pages:152-156
et al., 2019, Uterine transplantation in the context of a multi-organ retrieval in the UK, WILEY, Pages:192-192, ISSN:1470-0328
et al., 2019, Implementing uterine transplantation into multi-organ retrieval setting: specialist nurse in organ donation and intensive care nurse perspectives, WILEY, Pages:195-195, ISSN:1470-0328